Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
B-Ensure: Long-term Follow-up of Bepirovirsen in Chronic Hepatitis B
NCT07908459Phase 4Not yet recruiting
- Sponsor
- GSK
- Start
- Dec 2026
- Primary completion
- Dec 2030
01
Overview
A Phase 4 trial of bepirovirsen in Chronic Hepatitis B (CHB), sponsored by GSK. Planned start Dec 2026; status: not yet recruiting.
02
Drugs
bepirovirsen
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on NCT07908459.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07908459.